Showing results (631-640 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|September 25, 1998
Harmonising adverse drug reaction terminology: the role of the Council for International Organizations of Medical SciencesJ Venulet, Z Bankowski
Drug Safety|September 25, 1998
Safety and tolerability of moxonidine in the treatment of hypertensionM Schachter, J Luszick, B Jäger, et al.
Drug Safety|June 19, 2012
Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidolAndrew J Muzyk, Amber Rayfield, Jane Y Revollo, et al.
Drug Safety|April 2, 2015
Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary interventionJoakim Alfredsson, Matthew T Roe
Drug Safety|March 10, 2015
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in UgandaHelen Ndagije, Victoria Nambasa, Elizabeth Namagala, et al.
Drug Safety|March 10, 2015
Computational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworksVassilis G Koutkias, Marie-Christine Jaulent
Drug Safety|July 23, 1998
Managing antipsychotic-induced acute and tardive dystoniaM Raja
Drug Safety|January 29, 2015
ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish SystemsLinda Härmark, Florence van Hunsel, Birgitta Grundmark
Drug Safety|November 1, 1990
Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramideS Y Kim, N L Benowitz
Drug Safety|November 1, 1990
Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcomaD J Grimes, M R Bowles, J A Buttsworth, et al.
Pageof 308